ATLN
NASDAQ · Life Sciences Tools & Services
Atlantic International Corp
$3.20
-0.15 (-4.48%)
Financial Highlights (FY 2026)
Revenue
780.11M
Net Income
-238,788,948
Gross Margin
10.7%
Profit Margin
-30.6%
Rev Growth
+1,182.1%
D/E Ratio
2.45
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 10.7% | 42.5% | 42.5% | 42.5% |
| Operating Margin | -5.2% | 16.4% | 14.8% | 16.8% |
| Profit Margin | -30.6% | 9.8% | 11.0% | 12.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 780.11M | 137.50M | 128.72M | 150.34M |
| Gross Profit | 83.16M | 58.38M | 54.65M | 63.83M |
| Operating Income | -40,643,709 | 22.55M | 19.09M | 25.30M |
| Net Income | -238,788,948 | 13.41M | 14.17M | 19.27M |
| Gross Margin | 10.7% | 42.5% | 42.5% | 42.5% |
| Operating Margin | -5.2% | 16.4% | 14.8% | 16.8% |
| Profit Margin | -30.6% | 9.8% | 11.0% | 12.8% |
| Rev Growth | +1,182.1% | +9.2% | +17.5% | -9.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 64.88M | 64.08M | 61.68M | 71.70M |
| Total Equity | 26.53M | 174.87M | 149.24M | 163.17M |
| D/E Ratio | 2.45 | 0.37 | 0.41 | 0.44 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -199,345,204 | 31.52M | 29.06M | 36.12M |
| Free Cash Flow | — | 19.05M | 20.50M | 15.74M |